clinical trial · NCT01673620
A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)
Organon and Co·phase3·completed·n = 69
Allergic RhinitisMontelukast 10 mg/loratadine 10 mgPlacebo
brief summary
The purpose of this study is to assess the safety and tolerability of montelukast 10 mg/loratadine 10 mg versus placebo in Mexican participants with allergic rhinitis.
started
Jul 4, 2012
primary completion
Oct 10, 2012
completion
Oct 10, 2012
last updated
Sep 4, 2024
official title
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety of Combination Montelukast/Loratadine (MK-0476A) in Mexican Patients With Allergic Rhinitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol